NCT00230581 - 8 Weeks Treatment With DDP225 in Patients With Diarrhea Predominant IBS | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2005

Study Completion Date

August 31, 2007

Conditions

Irritable Bowel Syndrome

Interventions

DRUG

DDP225

Trial Locations (16)

Long Island Gastrointestinal Research, Great Neck

Radiant Research, Greer

Radiant Research, Mogadore

Radiant Research, St Louis

Radiant Research, Scottsdale

QE II Health Sciences Centre, Halifax

McMaster University Medical Centre, Hamilton

St. Joseph's Healthcare, Hamilton

Hotel Dieu Hospital, Kingston

St. Joseph's Healthcare, London

Meadowlands Family Health Centre, Ottawa

London Road Diagnostic Clinic, Sarnia

Sarnia Institute of Clinical Research, Sarnia

Toronto Digestive Disease Associates, Inc., Toronto

Hopital St-Sacrement, Québec

Canadian Phase Onward Inc., Toronto